MRNA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $8,531,936.40

Moderna Insider Trading History Chart

Moderna Share Price & Price History

^$51.38

▼ -0.99 (-1.89%)

As of 03/20/2026 05:00 PM ET

Days: 30 | 90 | 365

Moderna Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/23/2026	Stephen Hoge	President	Sell	160,009	$48.84	$7,814,839.56	1,457,427
12/11/2025	Noubar Afeyan	Director	Sell	23,853	$29.48	$703,186.44	3,924
12/9/2025	Abbas Hussain	Director	Sell	504	$27.60	$13,910.40	1,515
12/9/2024	Shannon Thyme Klinger	Insider	Sell	529	$44.68	$23,635.72	20,446
12/3/2024	Shannon Thyme Klinger	Insider	Sell	112	$43.30	$4,849.60	19,837
12/3/2024	Stephen Hoge	President	Sell	314	$43.30	$13,596.20	1,443,904
11/29/2024	Shannon Thyme Klinger	Insider	Sell	1,418	$42.79	$60,676.22	19,717
11/29/2024	Stephen Hoge	President	Sell	291	$42.79	$12,451.89	1,443,567
10/7/2024	Jamey M. Mock	CFO	Sell	715	$60.12	$42,985.80	9,505
9/3/2024	Shannon Thyme Klinger	Insider	Sell	114	$76.99	$8,776.86	17,566
9/3/2024	Stephen Hoge	President	Sell	318	$76.99	$24,482.82	1,443,002
8/29/2024	Shannon Thyme Klinger	Insider	Sell	162	$78.03	$12,640.86	17,447
8/29/2024	Stephen Hoge	President	Sell	300	$78.03	$23,409.00	1,442,668
8/28/2024	Jamey M. Mock	CFO	Sell	1,321	$79.39	$104,874.19	8,600
8/12/2024	Stephen Hoge	President	Sell	254	$84.10	$21,361.40	1,442,357
7/31/2024	Noubar Afeyan	Director	Sell	15,000	$119.96	$1,799,400.00	2,224,015
7/24/2024	Noubar Afeyan	Director	Sell	15,000	$117.80	$1,767,000.00	2,239,015
7/17/2024	Noubar Afeyan	Director	Sell	15,000	$122.84	$1,842,600.00	2,254,015
7/15/2024	Stephen Hoge	President	Sell	15,000	$121.12	$1,816,800.00	1,442,089
7/10/2024	Noubar Afeyan	Director	Sell	15,000	$117.08	$1,756,200.00	2,269,015
7/8/2024	Jamey M. Mock	CFO	Sell	689	$118.24	$81,467.36	7,269
6/26/2024	Noubar Afeyan	Director	Sell	15,000	$127.22	$1,908,300.00	2,284,015
6/17/2024	Stephen Hoge	President	Sell	15,000	$138.16	$2,072,400.00	1,457,089
6/11/2024	Noubar Afeyan	Director	Sell	202,832	$148.34	$30,088,098.88	1,528,557
6/10/2024	Shannon Thyme Klinger	Insider	Sell	5,178	$148.09	$766,810.02	15,947
6/5/2024	Noubar Afeyan	Director	Sell	15,000	$151.25	$2,268,750.00	1,946,931
5/29/2024	Noubar Afeyan	Director	Sell	20,000	$145.08	$2,901,600.00	1,961,931
5/29/2024	Stephen Hoge	President	Sell	341	$144.50	$49,274.50	1,471,777
5/28/2024	Jamey M. Mock	CFO	Sell	648	$162.47	$105,280.56	5,726
5/28/2024	Shannon Thyme Klinger	Insider	Sell	1,296	$162.47	$210,561.12	10,623
5/22/2024	Noubar Afeyan	Director	Sell	15,000	$157.57	$2,363,550.00	1,981,931
5/15/2024	Noubar Afeyan	Director	Sell	15,000	$127.32	$1,909,800.00	1,996,931
5/10/2024	Stephen Hoge	President	Sell	255	$120.96	$30,844.80	1,486,508
5/8/2024	Noubar Afeyan	Director	Sell	15,000	$121.68	$1,825,200.00	2,011,931
5/1/2024	Noubar Afeyan	Director	Sell	15,000	$110.92	$1,663,800.00	2,026,931
4/24/2024	Noubar Afeyan	Director	Sell	15,000	$108.32	$1,624,800.00	2,041,931
4/17/2024	Noubar Afeyan	Director	Sell	15,000	$103.38	$1,550,700.00	2,056,931
4/15/2024	Stephen Hoge	President	Sell	15,000	$105.02	$1,575,300.00	1,486,241
4/10/2024	Noubar Afeyan	Director	Sell	15,000	$107.12	$1,606,800.00	2,071,931
4/8/2024	Jamey M. Mock	CFO	Sell	705	$101.93	$71,860.65	5,048
4/3/2024	Noubar Afeyan	Director	Sell	15,000	$101.68	$1,525,200.00	2,086,931
3/27/2024	Noubar Afeyan	Director	Sell	15,000	$109.06	$1,635,900.00	2,101,931
3/20/2024	Noubar Afeyan	Director	Sell	15,000	$102.39	$1,535,850.00	2,116,931
3/13/2024	Noubar Afeyan	Director	Sell	15,000	$108.54	$1,628,100.00	2,131,931
3/8/2024	Shannon Thyme Klinger	Insider	Sell	544	$99.05	$53,883.20	9,267
2/29/2024	Jamey M. Mock	CFO	Sell	647	$94.57	$61,186.79	4,300
2/29/2024	Shannon Thyme Klinger	Insider	Sell	670	$94.57	$63,361.90	8,557
2/29/2024	Stephen Hoge	President	Sell	2,388	$94.57	$225,833.16	1,515,898
1/16/2024	Stephen Hoge	President	Sell	15,000	$103.90	$1,558,500.00	1,516,063
1/8/2024	Jamey M. Mock	CFO	Sell	772	$109.75	$84,727.00	3,632
12/27/2023	Stephen Hoge	President	Sell	45,000	$100.01	$4,500,450.00	1,531,063
12/27/2023	Stephen Hoge	President	Sell	45,000	$100.01	$4,500,450.00	1,531,063
12/8/2023	Shannon Thyme Klinger	Insider	Sell	563	$79.09	$44,527.67	7,912
12/6/2023	Arpa Garay	Insider	Sell	564	$78.34	$44,183.76	3,690
11/1/2023	Noubar Afeyan	Director	Sell	10,000	$76.00	$760,000.00	2,146,931
10/25/2023	Noubar Afeyan	Director	Sell	10,000	$76.99	$769,900.00	2,156,931
10/11/2023	Noubar Afeyan	Director	Sell	15,000	$103.30	$1,549,500.00	2,166,931
10/6/2023	Jamey M. Mock	CFO	Sell	2,858	$102.50	$292,945.00	2,952
10/4/2023	Noubar Afeyan	Director	Sell	15,000	$102.72	$1,540,800.00	2,181,931
9/27/2023	Noubar Afeyan	Director	Sell	10,000	$98.96	$989,600.00	2,196,931
9/20/2023	Noubar Afeyan	Director	Sell	15,000	$104.74	$1,571,100.00	2,206,931
9/15/2023	Stephen Hoge	President	Sell	15,000	$112.99	$1,694,850.00	1,574,187
9/13/2023	Noubar Afeyan	Director	Sell	15,000	$109.70	$1,645,500.00	2,221,931
9/8/2023	Shannon Thyme Klinger	Insider	Sell	557	$107.22	$59,721.54	7,215
9/6/2023	Noubar Afeyan	Director	Sell	15,000	$107.61	$1,614,150.00	1,982,209
9/5/2023	Shannon Thyme Klinger	Insider	Sell	115	$111.44	$12,815.60	6,634
8/30/2023	Noubar Afeyan	Director	Sell	15,000	$115.46	$1,731,900.00	1,997,209
8/29/2023	Stephen Hoge	President	Sell	1,135	$115.01	$130,536.35	1,588,855
8/23/2023	Noubar Afeyan	Director	Sell	15,000	$115.51	$1,732,650.00	2,012,209
8/17/2023	Stephen Hoge	President	Sell	15,000	$100.00	$1,500,000.00	1,587,579
8/16/2023	Noubar Afeyan	Director	Sell	10,000	$97.56	$975,600.00	2,027,209
8/10/2023	Stephen Hoge	President	Sell	247	$102.53	$25,324.91	1,602,579
8/2/2023	Noubar Afeyan	Director	Sell	15,000	$110.99	$1,664,850.00	2,037,209
7/26/2023	Noubar Afeyan	Director	Sell	15,000	$120.42	$1,806,300.00	2,052,209
7/19/2023	Noubar Afeyan	Director	Sell	15,000	$125.48	$1,882,200.00	2,067,209
7/17/2023	Stephen Hoge	President	Sell	15,000	$120.60	$1,809,000.00	1,602,303
7/12/2023	Noubar Afeyan	Director	Sell	15,000	$125.81	$1,887,150.00	2,082,209
7/5/2023	Noubar Afeyan	Director	Sell	15,000	$124.73	$1,870,950.00	2,097,209
6/28/2023	Noubar Afeyan	Director	Sell	15,000	$121.54	$1,823,100.00	2,112,209
6/28/2023	Stephane Bancel	CEO	Sell	27,155	$121.63	$3,302,862.65	5,411,946
6/21/2023	Noubar Afeyan	Director	Sell	15,000	$121.95	$1,829,250.00	2,127,209
6/21/2023	Stephane Bancel	CEO	Sell	40,000	$121.98	$4,879,200.00	5,411,946
6/15/2023	Stephen Hoge	President	Sell	15,000	$125.93	$1,888,950.00	1,617,303
6/14/2023	Stephane Bancel	CEO	Sell	40,000	$126.14	$5,045,600.00	5,411,946
6/7/2023	Noubar Afeyan	Director	Sell	15,000	$125.91	$1,888,650.00	2,157,209
6/2/2023	Shannon Thyme Klinger	Insider	Sell	110	$130.32	$14,335.20	5,942
6/2/2023	Stephen Hoge	President	Sell	309	$130.32	$40,268.88	1,632,303
5/31/2023	Noubar Afeyan	Director	Sell	15,000	$127.35	$1,910,250.00	2,172,209
5/31/2023	Stephane Bancel	CEO	Sell	40,000	$126.91	$5,076,400.00	5,411,946
5/30/2023	Stephen Hoge	President	Sell	1,181	$124.95	$147,565.95	1,631,961
5/24/2023	Stephane Bancel	CEO	Sell	40,000	$131.43	$5,257,200.00	5,411,946
5/10/2023	Stephane Bancel	CEO	Sell	40,000	$131.60	$5,264,000.00	5,411,946
5/10/2023	Stephen Hoge	President	Sell	250	$133.37	$33,342.50	1,630,732
4/27/2023	Stephane Bancel	CEO	Sell	40,000	$130.61	$5,224,400.00	5,411,946
4/20/2023	Stephane Bancel	CEO	Sell	40,000	$142.99	$5,719,600.00	5,411,946
4/12/2023	Stephane Bancel	CEO	Sell	40,000	$156.68	$6,267,200.00	5,411,946
4/5/2023	Stephane Bancel	CEO	Sell	40,000	$154.64	$6,185,600.00	5,411,946
3/30/2023	Stephane Bancel	CEO	Sell	40,000	$148.63	$5,945,200.00	5,411,946
3/22/2023	Stephane Bancel	CEO	Sell	40,000	$150.25	$6,010,000.00	5,411,946

SEC Filings (Institutional Ownership Changes) for Moderna (NASDAQ:MRNA)

75.33% of Moderna stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Moderna Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/20/2026	Hsbc Holdings PLC	638,370	$18.91M	0.0%	-14.4%	0.162%
3/17/2026	Rockefeller Capital Management L.P.	18,779	$0.55M	0.0%	-4.6%	0.005%
3/13/2026	World Investment Advisors	7,062	$0.21M	0.0%	-42.6%	0.002%
3/9/2026	Corient Private Wealth LLC	34,805	$1.03M	0.0%	+24.1%	0.009%
3/6/2026	Hsbc Holdings PLC	638,370	$18.91M	0.0%	-14.4%	0.162%
3/3/2026	Caitong International Asset Management Co. Ltd	2,153	$63K	0.0%	+21.9%	0.001%
3/2/2026	Sankala Group LLC	8,144	$0.24M	0.2%	N/A	0.002%
3/2/2026	Tobam	46,189	$1.36M	0.3%	-35.7%	0.012%
2/26/2026	Banque Transatlantique SA	20,418	$0.62M	0.0%	-21.1%	0.005%
2/24/2026	Pacer Advisors Inc.	27,246	$0.80M	0.0%	-57.3%	0.007%
2/23/2026	Virtu Financial LLC	82,217	$2.43M	0.1%	N/A	0.021%
2/19/2026	Hamilton Wealth LLC	105,066	$3.10M	0.6%	N/A	0.027%
2/19/2026	Invesco Ltd.	7,029,694	$207.31M	0.0%	-14.4%	1.799%
2/19/2026	Corient Private Wealth LLC	68,256	$2.01M	0.0%	+143.3%	0.017%
2/19/2026	Alberta Investment Management Corp	48,000	$1.42M	0.0%	N/A	0.012%
2/18/2026	Mercer Global Advisors Inc. ADV	108,650	$3.20M	0.0%	+1,111.0%	0.028%
2/18/2026	State of Tennessee Department of Treasury	77,015	$2.27M	0.0%	+103.6%	0.020%
2/18/2026	Mackenzie Financial Corp	11,767	$0.36M	0.0%	+5.1%	0.003%
2/18/2026	NewEdge Advisors LLC	1,016	$30K	0.0%	-93.4%	0.000%
2/18/2026	Empowered Funds LLC	13,732	$0.41M	0.0%	+2.6%	0.004%
2/18/2026	Voloridge Investment Management LLC	1,553,731	$45.82M	0.2%	+60.3%	0.398%
2/18/2026	Virtus Investment Advisers LLC	23,197	$0.68M	0.2%	+42.8%	0.006%
2/18/2026	Wellington Management Group LLP	83,295	$2.46M	0.0%	-3.8%	0.021%
2/18/2026	Susquehanna Portfolio Strategies LLC	471,043	$13.89M	0.2%	N/A	0.121%
2/18/2026	Tang Capital Management LLC	692,820	$20.43M	1.0%	+126.9%	0.177%
2/18/2026	Twinbeech Capital LP	281,214	$8.29M	0.6%	+30.9%	0.072%
2/18/2026	Suvretta Capital Management LLC	205,593	$6.06M	0.1%	N/A	0.053%
2/18/2026	Quadrature Capital Ltd	78,311	$2.31M	0.0%	-46.4%	0.020%
2/18/2026	Man Group plc	518,299	$15.29M	0.0%	-56.1%	0.133%
2/18/2026	Janus Henderson Group PLC	153,035	$4.51M	0.0%	-8.4%	0.039%
2/18/2026	Engineers Gate Manager LP	28,415	$0.84M	0.0%	-87.5%	0.007%
2/18/2026	Eversept Partners LP	267,823	$7.90M	0.4%	N/A	0.069%
2/18/2026	Cinctive Capital Management LP	72,376	$2.13M	0.1%	N/A	0.019%
2/18/2026	Banco Bilbao Vizcaya Argentaria S.A.	68,541	$2.03M	0.0%	-7.0%	0.018%
2/18/2026	Altshuler Shaham Ltd	23,000	$0.68M	0.0%	+43.8%	0.006%
2/17/2026	Guggenheim Capital LLC	65,325	$1.93M	0.0%	+4.1%	0.017%
2/17/2026	Schonfeld Strategic Advisors LLC	21,777	$0.64M	0.0%	N/A	0.006%
2/17/2026	AQR Capital Management LLC	12,010	$0.35M	0.0%	N/A	0.003%
2/17/2026	Coatue Management LLC	200,000	$5.90M	0.0%	N/A	0.051%
2/17/2026	EFG International AG	25,369	$0.75M	0.0%	N/A	0.006%
2/17/2026	Cetera Investment Advisers	63,447	$1.87M	0.0%	-12.7%	0.016%
2/17/2026	Jain Global LLC	26,759	$0.79M	0.0%	N/A	0.007%
2/17/2026	Amundi	1,143,613	$33.73M	0.0%	+12.6%	0.293%
2/17/2026	Jump Financial LLC	625,893	$18.46M	0.2%	+25.6%	0.160%
2/17/2026	Price T Rowe Associates Inc. MD	494,013	$14.57M	0.0%	+2.3%	0.126%
2/17/2026	Plustick Management LLC	130,000	$3.83M	1.7%	+116.7%	0.033%
2/17/2026	Weiss Asset Management LP	32,220	$0.95M	0.0%	N/A	0.008%
2/17/2026	Quantitative Investment Management LLC	28,399	$0.84M	0.1%	N/A	0.007%
2/17/2026	Osaic Holdings Inc.	43,824	$1.29M	0.0%	-2.1%	0.011%
2/17/2026	Twin Focus Capital Partners LLC	185,480	$5.47M	0.6%	N/A	0.047%
2/17/2026	Advisory Services Network LLC	4,587	$0.14M	0.0%	-57.0%	0.001%
2/17/2026	Himension Capital Singapore PTE. LTD.	57,728	$1.70M	0.1%	-13.4%	0.015%
2/17/2026	Public Employees Retirement System of Ohio	107,855	$3.18M	0.0%	-2.7%	0.028%
2/17/2026	California State Teachers Retirement System	348,661	$10.28M	0.0%	+6.7%	0.089%
2/17/2026	Russell Investments Group Ltd.	347,148	$10.25M	0.0%	+20.7%	0.089%
2/17/2026	State of Wisconsin Investment Board	227,942	$6.72M	0.0%	+0.8%	0.058%
2/17/2026	Captrust Financial Advisors	11,964	$0.35M	0.0%	+9.6%	0.003%
2/17/2026	ExodusPoint Capital Management LP	38,705	$1.14M	0.0%	-81.9%	0.010%
2/17/2026	Blair William & Co. IL	6,946	$0.21M	0.0%	-11.3%	0.002%
2/17/2026	Rakuten Investment Management Inc.	31,011	$0.97M	0.0%	+678.4%	0.008%
2/17/2026	Cynosure Group LLC	16,836	$0.50M	0.0%	N/A	0.004%
2/17/2026	Alberta Investment Management Corp	48,000	$1.42M	0.0%	N/A	0.012%
2/16/2026	Vanguard Personalized Indexing Management LLC	37,968	$1.12M	0.0%	-22.4%	0.010%
2/16/2026	Verition Fund Management LLC	452,529	$13.35M	0.1%	+103.5%	0.116%
2/16/2026	Wittenberg Investment Management Inc.	33,500	$0.99M	0.4%	N/A	0.009%
2/16/2026	Panagora Asset Management Inc.	44,758	$1.32M	0.0%	-0.6%	0.011%
2/16/2026	Fieldview Capital Management LLC	58,752	$1.73M	0.3%	N/A	0.015%
2/16/2026	Financial Gravity Asset Management Inc.	78,537	$2.32M	0.4%	+11.7%	0.020%
2/16/2026	Landscape Capital Management L.L.C.	22,347	$0.66M	0.0%	+97.6%	0.006%
2/13/2026	FORA Capital LLC	25,760	$0.76M	0.1%	N/A	0.007%
2/13/2026	Parkside Financial Bank & Trust	1,525	$45K	0.0%	-38.7%	0.000%
2/13/2026	The Manufacturers Life Insurance Company	447,680	$13.20M	0.0%	-1.8%	0.115%
2/13/2026	CANADA LIFE ASSURANCE Co	142,389	$4.20M	0.0%	-9.9%	0.036%
2/13/2026	Bridgewater Associates LP	15,181	$0.45M	0.0%	-93.2%	0.004%
2/13/2026	Stifel Financial Corp	57,253	$1.69M	0.0%	+290.8%	0.015%
2/13/2026	Hudson Bay Capital Management LP	244,594	$7.21M	0.0%	+344.7%	0.063%
2/13/2026	Neuberger Berman Group LLC	93,920	$2.77M	0.0%	+18.2%	0.024%
2/13/2026	Commerce Bank	34,667	$1.02M	0.0%	+7.1%	0.009%
2/13/2026	Bank of Nova Scotia	64,346	$1.90M	0.0%	+98.1%	0.016%
2/13/2026	Morgan Stanley	8,870,716	$261.60M	0.0%	-11.0%	2.270%
2/13/2026	Jacobs Levy Equity Management Inc.	216,476	$6.38M	0.0%	-85.1%	0.055%
2/13/2026	Public Sector Pension Investment Board	88,500	$2.61M	0.0%	+18.5%	0.023%
2/13/2026	AXA S.A.	10,905	$0.32M	0.1%	N/A	0.003%
2/13/2026	Rafferty Asset Management LLC	237,831	$7.01M	0.0%	-37.6%	0.061%
2/13/2026	Arkadios Wealth Advisors	24,346	$0.72M	0.0%	+85.4%	0.006%
2/13/2026	First Trust Advisors LP	1,501,621	$44.28M	0.0%	+45.4%	0.384%
2/13/2026	Itau Unibanco Holding S.A.	2,174	$64K	0.0%	+118.5%	0.001%
2/13/2026	Alyeska Investment Group L.P.	3,228,531	$95.21M	0.3%	N/A	0.826%
2/13/2026	Ausdal Financial Partners Inc.	7,309	$0.22M	0.0%	N/A	0.002%
2/13/2026	Charles Schwab Investment Management Inc.	4,621,558	$136.29M	0.0%	+7.2%	1.183%
2/13/2026	Police & Firemen s Retirement System of New Jersey	52,763	$1.56M	0.0%	-7.6%	0.014%
2/13/2026	Van ECK Associates Corp	228,034	$6.73M	0.0%	-15.7%	0.058%
2/13/2026	State Street Corp	16,365,478	$482.62M	0.0%	-4.3%	4.188%
2/13/2026	Saxon Interests Inc.	11,652	$0.34M	0.1%	N/A	0.003%
2/13/2026	Caitong International Asset Management Co. Ltd	2,153	$63K	0.2%	+21.9%	0.001%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,589,163	$46.86M	0.0%	-19.0%	0.407%
2/13/2026	Wells Fargo & Company MN	124,807	$3.68M	0.0%	+11.1%	0.032%
2/13/2026	Y Intercept Hong Kong Ltd	460,853	$13.59M	0.3%	N/A	0.118%
2/13/2026	Banco Santander S.A.	207,149	$6.11M	0.0%	-4.1%	0.053%
2/13/2026	Macquarie Group Ltd.	14,421	$0.43M	0.0%	-48.6%	0.004%

Data available starting January 2016

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $51.38

$50.62

$52.98

50 Day Range

MA: $47.38

$33.84

$57.80

52 Week Range

Now: $51.38

$22.28

$59.55

Volume

15,473,674 shs

Average Volume

9,275,282 shs

Market Capitalization

$20.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Moderna?: Moderna's top insider shareholders include:
Noubar Afeyan (Director)
Stephen Hoge (President)
Shannon Thyme Klinger (Insider)
James M Mock (CFO)
Abbas Hussain (Director)
Learn More about top insider investors at Moderna.
Who are the major institutional investors of Moderna?: Moderna's top institutional investors include:
Vanguard Group Inc. — 10.64%
Baillie Gifford & Co. — 5.27%
State Street Corp — 4.19%
Capital World Investors — 3.28%
Geode Capital Management LLC — 2.36%
Morgan Stanley — 2.27%
Learn More about top institutional investors of Moderna stock.
Which major investors are selling Moderna stock?: Within the last quarter, MRNA stock was sold by these institutional investors:
Squarepoint Ops LLC
Baillie Gifford & Co.
Jacobs Levy Equity Management Inc.
Invesco Ltd.
Morgan Stanley
State Street Corp
Jane Street Group LLC
Man Group plc
In the last year, company insiders that have sold Moderna company stock include:
Noubar Afeyan (Director)
Stephen Hoge (President)
Shannon Thyme Klinger (Insider)
Learn More investors selling Moderna stock.
Which major investors are buying Moderna stock?: Within the previous quarter, MRNA stock was acquired by institutional investors including:
Capital World Investors
UBS Group AG
Alyeska Investment Group L.P.
Norges Bank
Goldman Sachs Group Inc.
Whitefort Capital Management LP
Dimensional Fund Advisors LP
Voloridge Investment Management LLC